Research article · 12 Jun 2025
Conference abstractPublished 2016
Enabling rational design and development of nano-medicines: The nano-assemblerTM platform
Schaefer Technologie GmbH, Germany Precision NanoSystems Inc., Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In the past decade a considerable progress in understanding the interaction of organisms. With nano-medicine was achieved. While exciting discoveries are made in the research field, the translation of Nanomedicine from the bench to clinics remains challenging, notably due to the fact that incumbent formulation methods for producing Nanomedicine are labour-intensive, inconsistent and difficult to scale up. Moreover, the lack of control over some of the most basic characteristics of nanoparticles, size and polydispersity limit the ability to rationally design in vitro and in vivo studies. Here we introduce the NanoAssemblr™ Platform, which uses custom engineered microfluidic cartridges to perform nanoprecipitation within milliseconds and nanoliter reaction volumes. This enables well controlled, bottom-up self-assembly of nanoparticles such as RNA lipid nanoparticles, liposomes and polymeric nanoparticles with tunable sizes and low poly dispersity in one single step. Full automation of the system allows for high reproducibility of batches and excellent transferability of protocols between users. Varying parameters, such as total flow rate or flow ratio of the fluids, in the microfluidic channel can allow control over the size and polydispersity of the resulting nanoparticles, e.g. liposomes. The NanoAssemblr™ Benchtop Instrument facilitates rapid formulation screening at volumes between 1-15mL making it ideal for low-cost formulation and process development. Prototype formulations are easily scaled-up with the Nano Assemblr™ Scale Up Device, which uses parallel microfluidic mixers. Incorporating multiple mixers into a single microfluidic chip increases the throughput while maintaining identical reaction conditions. This technique allows for massive parallelization to achieve production scales from milliliters to litres.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “M Bartok”
- BylineArticles whose byline prints “L Jansen”
- BylineArticles whose byline prints “A Thomas”
- BylineArticles whose byline prints “G Heuck”
- BylineArticles whose byline prints “E Ramsay”
